SK Biopharmaceuticals builds an AI drug-discovery dataset of 7 million-plus chemical entries for a Korean programme
The dataset covers 66 tasks including toxicity, target interaction and clinical-trial outcome prediction, and a drug-discovery model built with Trillion Labs was tested on it; the company belongs to a Lunit-led consortium in the science ministry's programme.